Navigation Links
CorMedix to Report Third Quarter Financial Results on November 19, 2013
Date:11/15/2013

BRIDGEWATER, N.J., Nov. 15, 2013 /PRNewswire/ -- CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardio-renal and infectious disease, today announced that the Company will report financial results for the third quarter ended September 30, 2013 after the close of trading on Tuesday, November 19, 2013.

CorMedix has filed form 12b-25 with the U.S. Securities and Exchange Commission (the "SEC"), and as a result, the deadline for the Company to file its quarterly report on Form 10-Q with the SEC has been extended to November 19, 2013.

CorMedix management will hold a conference call on Wednesday, November 20, 2013, at 9a.m. EST to discuss the results and provide an update on recent business developments.  To access the call, please dial 1-866-866-1333 in the United States, and 1-404-260-1421 internationally.  A live webcast of the conference call will also be available on the investor relations page of the Company's website at www.cormedix.com.

For those unable to participate, a telephonic replay of the call will be available until December 4, 2013.  The replay dial-in numbers are 1-866-430-1300 for domestic callers and 1-404-260-1414 for international callers.  Please use event PIN 4804300 and confirmation number 201311142204363 to access the replay. Additionally, an archived webcast of the event will be available on the CorMedix website for 90 days.

About CorMedix

CorMedix Inc. is a development-stage pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases. CorMedix's most advanced product candidate is Neutrolin®, catheter lock solution for the prevention of catheter related bloodstream infections and maintenance of catheter patency in tunneled, cuffed, central venous catheters used for vascular access in hemodialysis patients. Please see the company's website at www.cormedix.com for additional information.

(Logo: http://photos.prnewswire.com/prnh/20130715/NY47431LOGO )


'/>"/>
SOURCE CorMedix Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CorMedix Inc. Closes $3,000,000 Preferred Stock Offerings
2. CorMedix Reports Receipt of European Patent Office Decision to Allow Prosl Patent to Proceed in European Union
3. CorMedix Reports Second Quarter 2013 Results
4. CorMedix Granted Extension of NYSE MKT Listing
5. ULURU Inc. Reports Third Quarter 2013 Financial Results
6. China Pharma Holdings, Inc. Reports Third Quarter 2013 Financial Results
7. TPI Reports First Quarter Fiscal Year 2014 Financial Results
8. Nephros Reports Third Quarter 2013 Financial Results and Completes Bridge Financing
9. Vermillion Reports Third Quarter 2013 Results
10. Global Radiopharmaceutical Market 2012-2016 Reports
11. SPO Global Reports Results for Third Quarter 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... WASHINGTON , Feb. 23, 2017  As ... tips.  In addition, the Company is helping people ... through its customized prescription savings programs in all ... Florida Prescription Assistance Program  and  California Prescription Assistance ... tips from Columbia University for nutritious ...
(Date:2/23/2017)... Ga., Feb. 23, 2017  MiMedx Group, Inc. (NASDAQ: ... tissue and patent-protected processes to develop and market advanced ... Spine, Sports Medicine, Ophthalmic, and Dental sectors of healthcare, ... and full year ended December 31, 2016. ... Revenue is a 31% increase over full year 2015 ...
(Date:2/23/2017)... 2017 LG Innotek today announced that the company has ... its sterilization performance is 1.5 times higher than the competitor,s 45mW ... in the range of 200 -- 280nm, allowing it to be used ... their DNA. LG Innotek,s product emits UV in the range of ... Until now, ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information Services ... National Institute for Health and Care Excellence (NICE) framework. The agreement allows ... Service (NHS) to search, order and purchase medical and healthcare-related content through ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... interactive publication where generations converge and explore the world from different perspectives. By ... Magazine enables readers to gain understanding, increase empathy, and find greater happiness. ...
(Date:2/23/2017)... ... February 23, 2017 , ... Healthcare ... for those in the fight against cancer, has produced a seminal study that ... HRA will release top-line findings in a webinar, Defining Compassionate Care Through the ...
(Date:2/23/2017)... Ramon, CA (PRWEB) , ... February 23, 2017 , ... ... MD, FACP, FACMPE, FACPE, will keynote their upcoming conference – Empowerment, Value and Collaboration ... as the chairman and CEO of the Virginia Mason Health System in Seattle since ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... HealthPostures, the ... sending an expert sit stand solutions representative to the Minneapolis Home and Garden Show ... for the event that is garnering national attention is the Minneapolis Convention Center. ...
Breaking Medicine News(10 mins):